Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma.
about
Trabectedin: safety and efficacy in the treatment of advanced sarcomaA Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to knowLiposarcoma: molecular genetics and therapeutics.A rare case of paratesticular leiomyosarcoma.
P2860
Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@ast
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@en
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@nl
type
label
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@ast
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@en
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@nl
prefLabel
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@ast
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@en
Trabectedin: the evidence for ...... atment of soft tissue sarcoma.
@nl
P2860
P356
P1433
P1476
Trabectedin: the evidence for ...... eatment of soft tissue sarcoma
@en
P2093
Katherine A Thornton
P2860
P304
P356
10.2147/CE.S5993
P407
P577
2010-06-15T00:00:00Z